Swiss National Bank - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$3,234,312
-2.8%
208,8000.0%0.00%0.0%
Q1 2024$3,328,272
+4.7%
208,800
+10.4%
0.00%0.0%
Q4 2023$3,178,771
+22.2%
189,100
-15.0%
0.00%0.0%
Q3 2023$2,601,025
-11.4%
222,500
+1.8%
0.00%0.0%
Q2 2023$2,936,640
-17.0%
218,500
+2.4%
0.00%0.0%
Q1 2023$3,538,172
-19.4%
213,400
-9.5%
0.00%
-33.3%
Q4 2022$4,387,740
+47.6%
235,900
+1.8%
0.00%
+50.0%
Q3 2022$2,973,000
+83.1%
231,7000.0%0.00%
+100.0%
Q2 2022$1,624,000
-15.5%
231,7000.0%0.00%0.0%
Q1 2022$1,921,000
+30.5%
231,700
+6.6%
0.00%0.0%
Q4 2021$1,472,000
+27.8%
217,4000.0%0.00%0.0%
Q3 2021$1,152,000
-7.8%
217,4000.0%0.00%0.0%
Q2 2021$1,250,000
+20.5%
217,400
-3.4%
0.00%0.0%
Q1 2021$1,037,000
+41.7%
225,000
+2.6%
0.00%0.0%
Q4 2020$732,000
+12.4%
219,3000.0%0.00%0.0%
Q3 2020$651,000
-35.7%
219,3000.0%0.00%0.0%
Q2 2020$1,013,000
+46.2%
219,300
+21.9%
0.00%0.0%
Q1 2020$693,000
+4.2%
179,900
+1.5%
0.00%0.0%
Q4 2019$665,000
-27.2%
177,300
+3.0%
0.00%0.0%
Q3 2019$914,000
+38.3%
172,1000.0%0.00%0.0%
Q2 2019$661,000172,1000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders